RhumbLine Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.35M | Sell |
|
|||||
|
2020
Q4 | $1.61M | Buy |
|
|||||
|
2020
Q3 | $1.54M | Sell |
|
|||||
|
2020
Q2 | $1.77M | Buy |
|
|||||
|
2020
Q1 | $386K | Sell |
|
|||||
|
2019
Q4 | $453K | Buy |
|
|||||
|
2019
Q3 | $563K | Sell |
|
|||||
|
2019
Q2 | $622K | Buy |
|
|||||
|
2019
Q1 | $638K | Sell |
|
|||||
|
2018
Q4 | $447K | Buy |
|
|||||
|
2018
Q3 | $337K | Sell |
|
|||||
|
2018
Q2 | $313K | Buy |
|
|||||
|
2018
Q1 | $238K | Sell |
|
|||||
|
2017
Q4 | $185K | Sell |
|
|||||
|
2017
Q3 | $474K | Buy |
|
|||||
|
2017
Q2 | $573K | Buy |
|
|||||
|
2017
Q1 | $616K | Buy |
|
|||||
|
2016
Q4 | $560K | Sell |
|
|||||
|
2016
Q3 | $557K | Buy |
|
|||||
|
2016
Q2 | $403K | Buy |
|
|||||
|
2016
Q1 | $218K | Buy |
|
|||||
|
2015
Q4 | $317K | Buy |
|
|||||
|
2015
Q3 | $294K | Buy |
|
|||||
|
2015
Q2 | $325K | Sell |
|
|||||
|
2015
Q1 | $506K | Buy |
|
|||||
|
2014
Q4 | $439K | Buy |
|
|||||
|
2014
Q3 | $281K | Hold |
|
|||||
|
2014
Q2 | $423K | Buy |
|
|||||
|
2014
Q1 | $255K | Sell |
|
|||||
|
2013
Q4 | $361K | Buy |
|
|||||
|
2013
Q3 | $314K | Buy |
|
|||||
|
2013
Q2 | $264K | Buy |
|